Ramipril and Eosinophil count decreased - a phase IV clinical study of FDA data


Eosinophil count decreased is found among people who take Ramipril, especially for people who are female, 50-59 old.

The phase IV clinical study analyzes which people take Ramipril and have Eosinophil count decreased. It is created by eHealthMe based on reports of 123,232 people who have side effects when taking Ramipril from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2022

123,232 people reported to have side effects when taking Ramipril.
Among them, 28 people (0.02%) have Eosinophil count decreased.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 126,177 Ramipril users for its effectiveness, alternative drugs and more.

What is Eosinophil count decreased?

Eosinophil count decreased is found to be associated with 620 drugs and 363 conditions by eHealthMe.

Number of Ramipril and Eosinophil count decreased reports submitted per year:

Could Ramipril cause Eosinophil count decreased?

Gender of people who have Eosinophil count decreased when taking Ramipril *:

  • female: 60.87 %
  • male: 39.13 %

Age of people who have Eosinophil count decreased when taking Ramipril *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 9.09 %
  • 40-49: 4.55 %
  • 50-59: 50.0 %
  • 60+: 36.36 %

Common drugs people take besides Ramipril *:

  1. Kisqali: 10 people, 35.71%
  2. Amlodipine: 6 people, 21.43%
  3. Vitamin D3: 4 people, 14.29%
  4. Clozaril: 4 people, 14.29%
  5. Amisulpride: 4 people, 14.29%
  6. Pantoprazole: 3 people, 10.71%
  7. Sulfatrim: 3 people, 10.71%
  8. Benadryl: 3 people, 10.71%
  9. Tylenol: 3 people, 10.71%
  10. Septra: 3 people, 10.71%

Common side effects people have besides Eosinophil count decreased *:

  1. Haemoglobin Decreased: 18 people, 64.29%
  2. C-Reactive Protein Increased: 18 people, 64.29%
  3. Blood Glucose Increased: 14 people, 50.00%
  4. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 14 people, 50.00%
  5. Red Blood Cell Count Decreased: 13 people, 46.43%
  6. Gamma-Glutamyltransferase Increased: 12 people, 42.86%
  7. Lymphocyte Count Increased: 12 people, 42.86%
  8. Thrombocytopenia (decrease of platelets in blood): 11 people, 39.29%
  9. Basophil Count Increased: 11 people, 39.29%
  10. Blood Potassium Decreased: 11 people, 39.29%

Common conditions people have *:

  1. Bone Pain: 10 people, 35.71%
  2. Breast Cancer Metastatic: 10 people, 35.71%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 14.29%
  4. Weight Decreased: 2 people, 7.14%
  5. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 7.14%
  6. Constipation: 2 people, 7.14%
  7. Depression: 2 people, 7.14%
  8. Psoriasis (immune-mediated disease that affects the skin): 2 people, 7.14%
  9. Affective Disorder (mental disorder): 2 people, 7.14%
  10. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Eosinophil count decreased?

Check whether Eosinophil count decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Eosinophil count decreased and when was it recovered:

Expand to all the drugs that have ingredients of ramipril:

Alternative drugs to, pros and cons of Ramipril:

Common Ramipril side effects:

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Eosinophil count decreased treatments and more:

COVID vaccines that are related to Eosinophil count decreased:

Common drugs associated with Eosinophil count decreased:

All the drugs that are associated with Eosinophil count decreased:

Common conditions associated with Eosinophil count decreased:

All the conditions that are associated with Eosinophil count decreased:

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: